logo

TMO

Thermo Fisher·NYSE
--
--(--)
--
--(--)
8.89 / 10
Outperform

TMO's fundamental profile is exceptionally strong, scoring 8.9/10. Key strengths include high cash-to-market value (0.1363, Q1), solid total assets turnover (0.4291, Q2), and healthy earnings growth (basic EPS +7.18% YoY, diluted EPS +7.32% YoY, both Q3). Cash-up is also favorable at 0.4658 (Q3). Only net cash flow from operations shows a dip (-9.7958, Q1), indicating room for improvement in cash generation. These metrics collectively earn a 'Outperform' fundamental rating.

Fundamental(8.89)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.14
Score3/3
Weight29.00%
1M Return6.60%
Net cash flow from operating activities / Operating revenue (%)
Value17.55
Score2/3
Weight1.93%
1M Return0.49%
Basic earnings per share (YoY growth rate %)
Value7.18
Score3/3
Weight14.86%
1M Return3.53%
Net cash flow from operating activities (YoY growth rate %)
Value-9.80
Score0/3
Weight-13.50%
1M Return-3.83%
Current assets turnover ratio
Value1.75
Score1/3
Weight-0.46%
1M Return-0.11%
Cash-UP
Value0.47
Score3/3
Weight17.81%
1M Return3.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value18.06
Score2/3
Weight-4.85%
1M Return-1.33%
Diluted earnings per share (YoY growth rate %)
Value7.32
Score3/3
Weight13.78%
1M Return3.35%
Total assets turnover ratio
Value0.43
Score2/3
Weight6.01%
1M Return1.47%
Cash-MV
Value0.14
Score3/3
Weight35.42%
1M Return5.91%
Is TMO undervalued or overvalued?
  • TMO scores 8.89/10 on fundamentals and holds a Discounted valuation at present. Backed by its 12.99% ROE, 15.08% net margin, 30.42 P/E ratio, 3.81 P/B ratio, and 7.18% earnings growth, these metrics solidify its Outperform investment rating.